ATE72459T1 - Herstellung von einschlussproteinfragmenten von menschlichem t-zellen-leukemia-(lymphotropischem)-retrovirus (htlv-1) in bakterien und verwendung fuer die seroloimologische pruefung von menschlicher lymphoid-malignitaet. - Google Patents

Herstellung von einschlussproteinfragmenten von menschlichem t-zellen-leukemia-(lymphotropischem)-retrovirus (htlv-1) in bakterien und verwendung fuer die seroloimologische pruefung von menschlicher lymphoid-malignitaet.

Info

Publication number
ATE72459T1
ATE72459T1 AT85307497T AT85307497T ATE72459T1 AT E72459 T1 ATE72459 T1 AT E72459T1 AT 85307497 T AT85307497 T AT 85307497T AT 85307497 T AT85307497 T AT 85307497T AT E72459 T1 ATE72459 T1 AT E72459T1
Authority
AT
Austria
Prior art keywords
human
htlv
seroloimological
malignity
lymphotropic
Prior art date
Application number
AT85307497T
Other languages
English (en)
Inventor
Takis S Papas
Flossie Wong-Staal
Kenneth Samuel
James A Lautenberger
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE72459T1 publication Critical patent/ATE72459T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT85307497T 1984-10-26 1985-10-17 Herstellung von einschlussproteinfragmenten von menschlichem t-zellen-leukemia-(lymphotropischem)-retrovirus (htlv-1) in bakterien und verwendung fuer die seroloimologische pruefung von menschlicher lymphoid-malignitaet. ATE72459T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66497284A 1984-10-26 1984-10-26
EP85307497A EP0181107B1 (de) 1984-10-26 1985-10-17 Herstellung von Einschlussproteinfragmenten von menschlichem T-Zellen-Leukemia-(lymphotropischem)-Retrovirus (HTLV-1) in Bakterien und Verwendung für die seroloimologische Prüfung von menschlicher Lymphoid-Malignität

Publications (1)

Publication Number Publication Date
ATE72459T1 true ATE72459T1 (de) 1992-02-15

Family

ID=24668194

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85307497T ATE72459T1 (de) 1984-10-26 1985-10-17 Herstellung von einschlussproteinfragmenten von menschlichem t-zellen-leukemia-(lymphotropischem)-retrovirus (htlv-1) in bakterien und verwendung fuer die seroloimologische pruefung von menschlicher lymphoid-malignitaet.

Country Status (10)

Country Link
EP (1) EP0181107B1 (de)
JP (2) JP2556965B2 (de)
AT (1) ATE72459T1 (de)
AU (1) AU569183B2 (de)
CA (1) CA1340878C (de)
DE (1) DE3585358D1 (de)
IE (1) IE63526B1 (de)
IL (1) IL76736A (de)
NZ (1) NZ213823A (de)
WO (1) WO1986002665A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62500452A (ja) * 1984-09-19 1987-02-26 ザ　リ−ジエンツ　オブ　ザ　ユニバ−シテイ　オブ　カリフオルニア ヒト細胞形質転換に関連するレトロウイルスポリペプチド
NZ218050A (en) * 1985-11-13 1989-05-29 Wistar Inst Test for the presence of htlv-1v
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
JP2501569B2 (ja) * 1986-11-14 1996-05-29 協和醗酵工業株式会社 抗成人ｔ細胞白血病ウイルス抗体の検出法
DE3787002T2 (de) * 1986-12-30 1993-11-25 Us Health Synthetische Peptide, die zelluläre Immunität gegen den AIDS-Virus und dessen Proteine erzeugen.
JPH01113663A (ja) * 1987-10-28 1989-05-02 Eisai Co Ltd Ａｔｌｖ抗体の測定試薬および測定方法
EP0345792A3 (de) * 1988-06-10 1991-05-02 F. Hoffmann-La Roche Ag HTLV-1/HIV-1-Fusionsproteine
ES2072346T3 (es) * 1989-10-23 1995-07-16 Hoffmann La Roche Peptidos sinteticos de la cubierta del htlv-i.
AU7258491A (en) * 1990-02-09 1991-09-03 E.I. Du Pont De Nemours And Company Htlv envelope antigenic segment
EP0848820A1 (de) * 1995-06-05 1998-06-24 Abbott Laboratories Nachweiss von htlv-antikörpern unter verwendung rekombinanteiweisse

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59104325A (ja) * 1982-12-07 1984-06-16 Japan Found Cancer ヒト白血病ウイルスの遺伝子ｒｎａに相補性を示すｄｎａ

Also Published As

Publication number Publication date
DE3585358D1 (de) 1992-03-19
IL76736A (en) 1990-12-23
IL76736A0 (en) 1986-02-28
JP2556965B2 (ja) 1996-11-27
IE63526B1 (en) 1995-05-03
WO1986002665A1 (en) 1986-05-09
EP0181107B1 (de) 1992-02-05
AU569183B2 (en) 1988-01-21
AU5013485A (en) 1986-05-15
CA1340878C (en) 2000-01-25
IE852646L (en) 1986-04-26
NZ213823A (en) 1988-05-30
JPS61502028A (ja) 1986-09-18
JPH09243640A (ja) 1997-09-19
JP2840820B2 (ja) 1998-12-24
EP0181107A1 (de) 1986-05-14

Similar Documents

Publication Publication Date Title
Bryan Vinblastine and microtubules: II. Characterization of two protein subunits from the isolated crystals
Sarngadharan et al. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS
AU5170585A (en) Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use
Hauser et al. Analysis of human T-lymphotropic virus sequences in multiple sclerosis tissue
ATE72459T1 (de) Herstellung von einschlussproteinfragmenten von menschlichem t-zellen-leukemia-(lymphotropischem)-retrovirus (htlv-1) in bakterien und verwendung fuer die seroloimologische pruefung von menschlicher lymphoid-malignitaet.
EP1245678A3 (de) Rekombinante Proteine von mit Lymphadenopathiesyndrom und/oder erworbenem Immunschwächesyndrom assoziierten Viren
CA2016313A1 (en) Process for preparing an improved western blot immunoassay
EP1475442A3 (de) Lymphotropische Polypeptide von dem Lentivirus von den T-zellen der Katze
JP3271666B2 (ja) Ｈｔｌｖ―ｉ、ｈｔｌｖ―ｉｉ又は関連レトロウイルスに対する抗体間の識別、新規ペプチド、抗体の検出及び免疫アッセイキット
Gombert et al. Antigenic epitopes of NEF proteins from different HIV-1 strains as recognized by sera from patients with manifest and latent HIV infection
ATE128716T1 (de) Hiv-peptide und methoden für den nachweis von hiv.
DE3879881D1 (de) Rekombinante hiv-2 polypeptide.
Kohtz et al. Immunological and structural homology between human T-cell leukemia virus type I envelope glycoprotein and a region of human interleukin-2 implicated in binding the beta receptor
US5420244A (en) Methods and compositions for diagnosing HTLV-I associated myelopathy and adult T-cell leukemia
Rohde et al. Bovine and ovine leukemia viruses. I. Characterization of viral antigens
Kuga et al. A gag‐env hybrid protein of human T‐cell leukemia virus type I and its application to serum diagnosis
Barone et al. Reactivity of E. coli-derived trans-activating protein of human T lymphotropic virus type III with sera from patients with acquired immune deficiency syndrome.
EP0246101A2 (de) Protein mit HTLV-I-antigener Aktivität und dessen Herstellung
US5674705A (en) Productive of human T-cell leukemia (lymphotropic) retrovirus (HTLV-1) envelope protein fragments in bacteria and use in seroepidemiological studies
Thiel et al. Interspecies reactivity of type C and D retrovirus p15E and p15C proteins
Rudolph et al. Detection of antibodies to trans-activator protein (p40taxI) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay.
EP0346091A2 (de) Verfahren zur Diagnose von natürlich vorkommenden Antikörpern gegen cd4
Bürgisser et al. Characterization of antibodies reacting with HIV gag proteins occasionally found in the serum of non-infected subjects
Leal et al. A visual immunoassay for HTLV-I/II serologic diagnosis
Baur et al. Discrimination of HIV-1 and HIV-2 infection based on recombinant immunoblots

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time